Matthew C. Somerville
About
Matthew C. Somerville is a scholar working on Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis and Surgery.
According to data from OpenAlex, Matthew C. Somerville has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 8 papers in Health, Toxicology and Mutagenesis and 7 papers in Surgery. Recurrent topics in Matthew C. Somerville's work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (13 papers) and Air Quality and Health Impacts (7 papers). Matthew C. Somerville is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (13 papers) and Air Quality and Health Impacts (7 papers). Matthew C. Somerville collaborates with scholars based in United States, United Kingdom and Canada. Matthew C. Somerville's co-authors include Roger S. Rittmaster, David G. Bostwick, Gerald L. Andriole, Leonard G. Gomella, Claus G. Roehrborn, Michael Marberger, Donald J. Tindall, Otis W. Brawley, J. Curtis Nickel and Michael P. O’Leary and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Matthew C. Somerville
51 papers receiving 2.7k citations
Hit Papers
Peers
Matthew C. Somerville
Francesco Del Giudice Italy
Katsuya Nonomura Japan
Michel Baum United States
Ronald G. Munger United States
Haiying Zhang China
Juhyun Park South Korea
Bronwyn Stuckey Australia
Fumihiro Sata Japan
L N Kolonel United States
Shoji Tokunaga Japan
Citations per year, relative to Matthew C. Somerville Matthew C. Somerville (= 1×)
peers
Francesco Del Giudice
Countries citing papers authored by Matthew C. Somerville
Since
Specialization
Citations
This map shows the geographic impact of Matthew C. Somerville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Somerville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Somerville more than expected).
Fields of papers citing papers by Matthew C. Somerville
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Matthew C. Somerville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Somerville. The network helps show where Matthew C. Somerville may publish in the future.
Co-authorship network of co-authors of Matthew C. Somerville
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew C. Somerville. A scholar is included among the top collaborators of Matthew C. Somerville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew C. Somerville. Matthew C. Somerville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Silverberg, Jonathan I., Lawrence F. Eichenfield, Adelaide A. Hebert, et al.. (2024). Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials. Journal of the American Academy of Dermatology. 91(3). 457–465.
2.
Silverberg, Jonathan I., Lawrence F. Eichenfield, Adelaide A. Hebert, et al.. (2023). Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Atopic Dermatitis in Two Pivotal Phase 3 Trials in Adults and Children Down to 2 Years of Age. SKIN The Journal of Cutaneous Medicine. 7(6). s283–s283.
3.
Parish, Lawrence Charles, et al.. (2021). Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics. American Journal of Clinical Dermatology. 23(1). 83–91.
4.
Yohn, Samantha E., et al.. (2016). Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology. Neuropharmacology. 109. 270–280.
5.
Chu, Franklin, et al.. (2015). A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer. European Journal of Cancer. 51(12). 1555–1569.
6.
Andriole, Gerald L., David G. Bostwick, Otis W. Brawley, et al.. (2010). Effect of Dutasteride on the Risk of Prostate Cancer. New England Journal of Medicine. 362(13). 1192–1202.
7.
Somerville, Matthew C., et al.. (2010). Effect of NRG1, GDNF, EGF and NGF in the Migration of a Schwann Cell Precursor Line. Neurochemical Research. 35(10). 1643–1651.
8.
Andriole, G.L., David G. Bostwick, Otis W. Brawley, et al.. (2009). The utility of PSA for detection of prostate cancer in men treated with dutasteride: Results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) study. Journal of Men s Health. 6(3). 269–269.
9.
Shepherd, Jonathan, G Rogers, Ronald Anderson, et al.. (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technology Assessment. 12(19). iii–iv, 1.
10.
Main, Caroline, Jonathan Shepherd, Ronald Anderson, et al.. (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technology Assessment. 12(20). 1–174, iii.
11.
Somerville, Matthew C., Ruth Garside, Martin Pitt, & Ken Stein. (2008). Surveillance of Barrett’s oesophagus: Is it worthwhile?. European Journal of Cancer. 44(4). 588–599.
12.
Fleshner, Neil, Leonard G. Gomella, Michael S. Cookson, et al.. (2007). Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. Contemporary Clinical Trials. 28(6). 763–769.
13.
Garside, Ruth, Martin Pitt, Rob Anderson, et al.. (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technology Assessment. 11(45). iii–iv, ix.
14.
Nickel, J. Curtis, Claus G. Roehrborn, Michael P. O’Leary, et al.. (2007). The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial. European Urology. 54(6). 1379–1384.
15.
Andriole, Gerald L., Claus G. Roehrborn, C. Schulman, et al.. (2004). Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. Urology. 64(3). 537–541.
16.
Andriole, Gerald L., David G. Bostwick, Otis W. Brawley, et al.. (2004). CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL. The Journal of Urology. 172(4 Part 1). 1314–1317.
17.
Rivera, Edgardo, Linda Sutton, Bruce Colwell, et al.. (2002). Multicenter Phase II Study of a 28-Day Regimen of Orally Administered Eniluracil and Fluorouracil in the Treatment of Patients With Anthracycline- and Taxane-Resistant Advanced Breast Cancer. Journal of Clinical Oncology. 20(4). 987–993.
18.
Mukerjee, Shaibal, et al.. (2001). Techniques to assess cross-border air pollution and application to a US-Mexico border region. The Science of The Total Environment. 276(1-3). 205–224.
19.
Mukerjee, Shaibal, William D. Ellenson, Robert G. Lewis, et al.. (1997). An environmental scoping study in the Lower Rio Grande Valley of Texas — I. Comparative assessment of air sampling methods. Environment International. 23(5). 611–628.
20.
Lesser, Virginia M., J. O. Rawlings, Susan E. Spruill, & Matthew C. Somerville. (1990). Ozone Effects on Agricultural Crops: Statistical Methodologies and Estimated Dose‐Response Relationships. Crop Science. 30(1). 148–155.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Francesco Del Giudice Breakdown of academic impact, for papers by Katsuya Nonomura Breakdown of academic impact, for papers by Michel Baum Breakdown of academic impact, for papers by Ronald G. Munger Breakdown of academic impact, for papers by Haiying Zhang Breakdown of academic impact, for papers by Juhyun Park Breakdown of academic impact, for papers by Bronwyn Stuckey Breakdown of academic impact, for papers by Fumihiro Sata Breakdown of academic impact, for papers by L N Kolonel Breakdown of academic impact, for papers by Shoji Tokunaga